Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference...

Insulet Corporation to Present at the Thomas Weisel Partners Healthcare
Conference on September 3, 2008

BEDFORD, Mass., Aug. 27 /PRNewswire-FirstCall/ -- Insulet Corporation
(Nasdaq: PODD), the leader in patch pump technology with its OmniPod(R)
Insulin Management System, today announced the company will participate in the
Thomas Weisel Partners Healthcare Conference. Management is scheduled to
present an overview of the Company at 10:20 a.m. EDT on September 3, 2008 at
The Four Seasons in Boston, MA.
During the conference presentation, material information concerning the
Company, its operations, strategies and prospects may be discussed. To listen
to the audio webcast of the presentation during the event, please visit:
http://investors.insulet.com. A replay of the webcast will be available for 30
days.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to
improving the lives of people with diabetes. The Company's OmniPod Insulin
Management System is a revolutionary, discreet and easy-to-use insulin
infusion system that features two easy-to-use parts with no tubing and
fully-automated cannula insertion. Through the OmniPod System, Insulet seeks
to expand the use of continuous subcutaneous insulin infusion (CSII) therapy
among people with insulin-dependent diabetes. Founded in 2000, Insulet is
based in Bedford, MA.
Contact:
Stephanie Marks for Insulet Corporation
ir@insulet.com
877-PODD-IR1 (877-763-3471)

SOURCE Insulet Corporation

Stephanie Marks for Insulet Corporation, +1-877-763-3471, ir@insulet.com